Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BCRX BioCryst Pharmaceuticals Inc

6,49

0,36 (5,87%)

22 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more BioCryst Pharmaceuticals Charts.

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more BioCryst Pharmaceuticals Charts.

News BioCryst Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
Dienstag 14 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

ORLADEYO® (berotralstat) Approved in Mexico
Montag 13 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

BioCryst to Present at Upcoming Investor Conferences
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 6 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Weitere BioCryst Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen